Lexicon Pharmaceuticals (LXRX) Reports Mixed Q4 Results

February 22, 2012 6:55 AM EST
Get Alerts LXRX Hot Sheet
Price: $2.35 --0%

Financial Fact:
Interest expense: -1.65M

Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q4 EPS of ($0.10), $0.02 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $343 thousand versus the consensus estimate of $290 thousand.

For earnings history and earnings-related data on Lexicon Pharmaceuticals (LXRX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings